Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients

AIMS: The aim of this study was to develop and validate a population pharmacokinetic model of ritonavir, used as an antiviral agent or as a booster, in a large patient population and to identify factors influencing its pharmacokinetics. METHODS: Ambulatory HIV-1-infected patients from the outpatient...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kappelhoff, Bregt S, Huitema, Alwin D R, Crommentuyn, Kristel M L, Mulder, Jan W, Meenhorst, Pieter L, van Gorp, Eric C M, Mairuhu, Albert T A, Beijnen, Jos H
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2005
Témata:
Pharmacokinetics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884743/
https://ncbi.nlm.nih.gov/pubmed/15676039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2004.02241.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky